ONESOURCE SPECIALTY PHARMA
Sector : Pharmaceuticals and health care | Midcap | BSE
Here's the live share price of OneSource Specialty Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
1.35₹ 23.55
As on Jan 13, 2026, 4:01 PM IST
OneSource Specialty Pharma Price Performance
Today's LowToday's High
₹1,703.45₹1,781.80
₹1,768.95
52 Weeks' Low52 Weeks' High
₹1,163.05₹2,249.65
₹1,768.95
Open Price
₹1,713.65
Prev. Close
₹1,745.40
Volume
2,537
Over the last 5 years, the share price of OneSource Specialty Pharma has gained 0.77% CAGR. Over the past year, the corresponding return has been 3.90%.
OneSource Specialty Pharma’s current P/E of 507.36x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
OneSource Specialty Pharma Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| OneSource Specialty Pharma | -1.64 | 9.59 | -4.29 | -11.48 | 3.90 | 1.28 | 0.77 |
| Sun Pharmaceutical Industries | -1.72 | -3.75 | 3.67 | 2.84 | -0.93 | 18.84 | 23.50 |
| Divi's Laboratories | -3.17 | 1.37 | -1.84 | -5.15 | 12.25 | 24.28 | 11.57 |
| Torrent Pharmaceuticals | 0.08 | 4.21 | 11.94 | 15.64 | 21.65 | 36.43 | 23.28 |
| Cipla | -5.37 | -3.92 | -7.40 | -2.46 | 0.65 | 10.67 | 11.47 |
| Dr. Reddy's Laboratories | -5.22 | -7.03 | -5.67 | -4.84 | -10.78 | 11.24 | 2.38 |
| Lupin | 0.87 | 3.85 | 10.17 | 12.78 | 0.77 | 42.16 | 15.25 |
| Mankind Pharma | -1.47 | 3.08 | -9.53 | -18.18 | -14.73 | 15.76 | 9.18 |
| Zydus Lifesciences | -3.44 | -2.39 | -9.49 | -7.15 | -7.70 | 26.78 | 13.06 |
| Alkem Laboratories | 3.75 | 4.42 | 6.66 | 21.15 | 12.13 | 24.64 | 13.69 |
| Aurobindo Pharma | -5.89 | -2.23 | 1.97 | 1.78 | -0.24 | 38.62 | 4.12 |
| Abbott India | -0.98 | 0.91 | -6.04 | -18.14 | -1.40 | 8.14 | 13.40 |
| Laurus Labs | -5.25 | 5.27 | 20.71 | 28.27 | 89.19 | 43.60 | 24.88 |
| Biocon | -2.30 | -3.67 | 7.70 | -0.79 | 3.12 | 14.27 | -4.07 |
| Glenmark Pharmaceuticals | -3.52 | 0.82 | 4.73 | -9.77 | 33.65 | 68.24 | 31.26 |
| GlaxoSmithKline Pharmaceuticals | -4.06 | -7.52 | -13.44 | -25.28 | 13.93 | 22.11 | 9.26 |
| Ipca Laboratories | 2.30 | 4.27 | 13.62 | 3.14 | -4.86 | 19.98 | 7.48 |
| Anthem Biosciences | -2.74 | -10.62 | -20.41 | -14.48 | -14.48 | -5.08 | -3.08 |
| Ajanta Pharma | -4.20 | 3.36 | 12.82 | 2.98 | -2.01 | 32.30 | 18.16 |
| Emcure Pharmaceuticals | 1.44 | 10.88 | 13.09 | 14.27 | 17.70 | 4.45 | 2.65 |
Over the last one year, OneSource Specialty Pharma has gained 3.90% compared to peers like Sun Pharmaceutical Industries (-0.93%), Divi's Laboratories (12.25%), Torrent Pharmaceuticals (21.65%). From a 5 year perspective, OneSource Specialty Pharma has underperformed peers relative to Sun Pharmaceutical Industries (23.50%) and Divi's Laboratories (11.57%).
OneSource Specialty Pharma Financials
OneSource Specialty Pharma Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,781.31 | 1,765.3 |
| 10 | 1,784.13 | 1,764.94 |
| 20 | 1,728.71 | 1,745.75 |
| 50 | 1,714.01 | 1,738.21 |
| 100 | 1,777.45 | 1,756.36 |
| 200 | 1,799.43 | 1,737.2 |
OneSource Specialty Pharma Share Holding Pattern
In the latest quarter, OneSource Specialty Pharma saw a drop in promoter holding to 29.78%, while DII stake increased to 18.48%, FII holding rose to 19.39%, and public shareholding moved down to 32.34% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
OneSource Specialty Pharma Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 24,63,348 | 2.49 | 377.43 | |
| 10,66,196 | 0.61 | 163.36 | |
| 7,97,281 | 2.75 | 122.16 | |
| 6,49,672 | 0.75 | 99.54 | |
| 4,85,952 | 0.3 | 74.46 | |
| 4,48,823 | 2.45 | 68.77 | |
| 4,40,404 | 1.06 | 67.48 | |
| 4,22,180 | 1.08 | 64.69 | |
| 3,44,085 | 3.47 | 52.72 | |
| 2,94,408 | 0.48 | 45.11 |
* Excluding Index & Arbitrage Funds
OneSource Specialty Pharma Corporate Actions
Date Time | Announcement |
|---|---|
| Jan 01, 2026, 12:46 AM IST | OneSource Specialty - Intimation Of The Press Release Of Credit Rating Under Regulation 30 Read With Schedule III Of The SEBI |
| Dec 11, 2025, 3:57 PM IST | OneSource Specialty - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS |
| Dec 09, 2025, 9:09 PM IST | OneSource Specialty - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS |
| Nov 18, 2025, 8:16 PM IST | OneSource Specialty - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| Nov 18, 2025, 5:13 PM IST | OneSource Specialty - Update On Non-Participation Of The Representatives Of The Company In The Jefferies Conference |
About OneSource Specialty Pharma
OneSource Specialty Pharma Ltd. is a Public Limited Listed company incorporated on 12/06/2007 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is U74140MH2007PLC432497 and registration number is 432497. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 1299.59 Cr. and Equity Capital is Rs. 11.44 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressUnit No. 902, Cyber One, Plot No - 4 & 6, Sector 30A, Vashi, Thane Maharashtra 400703
- Contact
Management
- Mr. Arun Kumar PillaiChairperson & Non Executive Director
- Mr. Neeraj SharmaManaging Director & CEO
- Ms. Debarati SenInd. Non-Executive Director
- Mr. Colin Michael BondInd. Non-Executive Director
- Mr. Bharat ShahNon Executive Director
- Mr. Vijay KarwalInd. Non-Executive Director
- Dr. Claudio AlbrechtInd. Non-Executive Director
- Dr. Rashmi H BarbhaiyaInd. Non-Executive Director
FAQs on OneSource Specialty Pharma Share Price
What is the share price of OneSource Specialty Pharma?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for OneSource Specialty Pharma is ₹1,768.95 as on Jan 13, 2026.
What kind of stock is OneSource Specialty Pharma?
The OneSource Specialty Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
What is the Market Cap of OneSource Specialty Pharma?
The market cap of OneSource Specialty Pharma is ₹20,269.54 Cr as on Jan 13, 2026.
What are today's High and Low prices of OneSource Specialty Pharma?
Today’s highest and lowest price of OneSource Specialty Pharma are ₹1,781.80 and ₹1,703.45.
What are the 52 Week High and 52 Week Low of OneSource Specialty Pharma?
The 52-week high/low is the highest and lowest price at which OneSource Specialty Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of OneSource Specialty Pharma is ₹2,249.65 and 52-week low of OneSource Specialty Pharma is ₹1,163.05 as on Jan 13, 2026.
How has the OneSource Specialty Pharma performed historically in terms of returns?
The OneSource Specialty Pharma has shown returns of 1.35% over the past day, 9.59% for the past month, -4.29% over 3 months, 3.9% over 1 year, 1.28% across 3 years, and 0.77% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of OneSource Specialty Pharma?
P/E ratio of and PB ratio of OneSource Specialty Pharma are 507.36 and 3.43 on Jan 13, 2026. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse